None listed
Conditions
Interventions
Dietary Supplement : • Agrimonia pilosa extract powder group: once a day, 1 capsule once, after breakfast(350 mg/day, 75 mg/day for Agrimonia pilosa extract powder)
• Placebo group: once a day, 1 caps
Sponsors
Wonkwang University, Gwangju Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Adult men and women aged 19 years or older and 75 years or less at the screening test 2) Participants whose blood ALT level within 46~135 U/L 3) A person who, after hearing and fully understanding the detailed explanation of this trial, voluntarily decides to participate and agrees in writing to comply with the precautions
Exclusion criteria
Exclusion criteria: 1) Acute or chronic hepatitis patients or individuals with Hepatitis B or Hepatitis C virus infection 2) Individuals with liver cirrhosis, liver cancer, or signs suggestive of liver cancer. 3) Individuals with a BMI of less than 18.5 kg/m^2 or greater than 35 kg/m^2 at screening 4) Those who have taken liver function improving drugs and health functional foods within 1 month prior to screening 5) Those with a history of clinically significant hypersensitivity to Agrimonia pilosa 6) Pregnant or lactating women 7) Women of childbearing potential who do not accept the practice of adequate contraception 8) Those who participated in other clinical trials within 3 months prior to screening 9) A person who is judged unsuitable for participation in the study by the director of the study due to diagnostic test results and other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ALT(Alanine Transaminase) | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver fuction index;Lipid metabolism index;Liver fatty index;Inflammation index | — |
Countries
Korea, Republic of
Contacts
Public ContactJin Hee Won
Wonkwang University, Gwangju Medical Center
Outcome results
None listed